Compounds > lucidin 3-o-beta-primveroside
Page last updated: 2024-11-07

lucidin 3-o-beta-primveroside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

lucidin 3-O-beta-primveroside: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID160180
CHEMBL ID521217
SCHEMBL ID23522435
MeSH IDM0177233

Synonyms (23)

Synonym
lucidin 3-o-primveroside
ccris 4532
lucidin primeveroside
lucidinprimeveroside
lucidin 3-o-beta-primveroside
glucopyranoside, 4-hydroxy-3-(hydroxymethyl)-2-anthraquinonyl 6-o-beta-d- xylopyranosyl-, beta-d-
29706-59-0
lucidin primevoroside
CHEMBL521217
1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione
1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-anthracene-9,10-dione
SCHEMBL23522435
lucidin 3-o-primeveroside
lucidin-3-beta-primeveroside
lucidin-primeveroside
9,10-anthracenedione, 1-hydroxy-2-(hydroxymethyl)-3-[(6-o-beta-d-xylopyranosyl-beta-d-glucopyranosyl)oxy]-
1-hydroxy-2-(hydroxymethyl)-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2s,3r,4s,5r)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)anthracene-9,10-dione
4-hydroxy-3-(hydroxymethyl)-9,10-dioxo-9,10-dihydroanthracen-2-yl 6-o-pentopyranosylhexopyranoside
DTXSID40952155
E88947
CS-0138995
HY-N8022
AKOS040760529
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID332373Inhibition of platelet activating factor-induced platelet aggregation in rabbit platelet assessed as aggregation at 300 uM treated 3 mins before platelet activating factor challenge by turbidimetric method1994Journal of natural products, Feb, Volume: 57, Issue:2
Antiplatelet constituents of formosan Rubia akane.
AID332370Inhibition of thrombin-induced platelet aggregation in rabbit platelet assessed as aggregation at 300 uM treated 3 mins before thrombin challenge by turbidimetric method1994Journal of natural products, Feb, Volume: 57, Issue:2
Antiplatelet constituents of formosan Rubia akane.
AID332372Inhibition of collagen-induced platelet aggregation in rabbit platelet assessed as aggregation at 300 uM treated 3 mins before collagen challenge by turbidimetric method1994Journal of natural products, Feb, Volume: 57, Issue:2
Antiplatelet constituents of formosan Rubia akane.
AID332371Inhibition of arachidonic acid-induced platelet aggregation in rabbit platelet assessed as aggregation at 300 uM treated 3 mins before arachidonic acid challenge by turbidimetric method1994Journal of natural products, Feb, Volume: 57, Issue:2
Antiplatelet constituents of formosan Rubia akane.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
pentachlorophenol
PENTA: structure given in first source		2.2110aromatic fungicide;
chlorophenol;
organochlorine pesticide;
pentachlorobenzenes		human xenobiotic metabolite
aspirin
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5). acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.. acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.		1.9810benzoic acids;
phenyl acetates;
salicylates		anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
alizarin
[no description available]		1.9810dihydroxyanthraquinonechromophore;
dye;
plant metabolite
1-hydroxyanthraquinone
[no description available]		1.9810monohydroxyanthraquinone
lucidin
lucidin: from Rubiatinctorum L. root		1.9810dihydroxyanthraquinone
ruberythric acid
ruberythric acid: structure given in first source		2.3820
rubiadin
rubiadin: highly genotoxic in Salmonella typhimurium. rubiadin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 3 and a methyl group at position 2. It has been isolated from Rubia yunnanensis.		1.9810dihydroxyanthraquinoneantibacterial agent;
antioxidant;
hepatoprotective agent;
plant metabolite
rubimaillin
rubimaillin: structure given in first source. rubimaillin : A benzochromene that is 2H-benzo[h]chromene which is substituted by two methyl groups at position 2, a methoxycarbonyl group at position 5, and a hydroxy group at position 6. Found in the Chinese medical plant Rubia cordifola, It has an anti-cancer effect by inhibition of TNF-alpha-induced NF-kappaB activation. It is also a dual inhibitor of acyl-CoA:cholesterol acyltransferase 1 and 2 (ACAT1 and ACAT2), but is more selective for the ACAT2 isozyme.		1.9810benzochromene;
methyl ester;
phenols		acyl-CoA:cholesterol acyltransferase 2 inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
neuroprotective agent;
NF-kappaB inhibitor;
plant metabolite
1-hydroxy-2-methylanthraquinone
1-hydroxy-2-methylanthraquinone: from root of Prismatomeris tetrandra. 1-hydroxy-2-methyl-9,10-anthraquinone : A member of the class of hydroxyanthraquinones that is anthracene-9,10-dione substituted by a hydroxy group at position 1 and a methyl group at position 2. It has been isolated from the roots of Rubia yunnanensis.		1.9810monohydroxyanthraquinoneplant metabolite
glycosides
[no description available]		1.9810
1,3,6-trihydroxy-2-methyl-9,10-anthraquinone
2-methyl-1,3,6-trihydroxy-9,10-anthraquinone: anthraquinone derivative. 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone : A trihydroxyanthraquinone that is 9,10-anthraquinone substituted by hydroxy groups at positions 1, 3 and 6 and a methyl group at position 2. It has been isolated from the roots of Rubia yunnanensis.		1.9810trihydroxyanthraquinoneplant metabolite
deoxyguanosine
[no description available]		2.0510purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
ConditionIndicatedRelationship StrengthStudiesTrials